Just another WordPress site

Cardiovascular Disease and Erectile Dysfunction

Sexual activity is accompanied by vascular changes involving the autonomic (or involuntary) nervous system. Sexual arousal causes the release of a neurotransmitter, nitrous oxide (NO) from the vascular endothelium (the layer of cells lining the inside area of blood vessels, including the heart). The vascular endothelium is a nitrous oxide (NO) secretor. Endothelial dysfunction (loss of correct endothelial function) is a characteristic feature of vascular diseases.

In the blood vessels of the penis, this nitrous oxide acts as a vasodilator messenger, stimulating the synthesis of a substance in the hollow bodies of the penis that makes the smooth vascular muscle relax, causing an erection. So, endothelial dysfunction will affect the NO mediating mechanism and result in erectile dysfunction.

It was found that 74% of patients with cardiovascular risk presented associated erectile dysfunction (ED).

ED is one of the most frequent chronic problems in males aged over 40, especially as it has been shown to be an early indicator of ischaemic cardiomyopathy. ED is regarded as synonymous with endothelial dysfunction, as a diseased endothelium that is unable to produce nitrous oxide (NO), or that degrades it rapidly as a consequence of arteriosclerosis, will cause erectile dysfunction (ED) in the penis and ischaemia in the coronary arteries.

Cardiovascular disease and sexual dysfunction share a high percentage of patients as they both involve a coincidence of underlying aetiology and risk factors (age, gender, hypertension, diabetes, hypercholesterolemia, smoking and depression). Added to this is the interaction between prescribed treatments. There are more than 200 pharmaceutical drugs that induce erectile dysfunction, many of which are used to treat cardiovascular disease, like diuretic and antihypertensive medication, and to treat depression.

ASSSA Medical Services

 

 

 

The information published in this media neither substitutes nor complements in any way the direct supervision of a doctor, his diagnosis or the treatment that he may prescribe. It should also not be used for self-diagnosis.

The exclusive responsibility for the use of this service lies with the reader.

ASSSA advises you to always consult your doctor about any issue concerning your health.

Return

Prostate Cancer

April 20, 2016 ASSSA Man

Prostate cancer is the third most common cause of cancer-related death in men, and the first amongst…

Erectile Dysfunction

June 15, 2016 ASSSA Man

Eerctile dysfunction can be organic or psychogenic. An interview with the patient can be very helpfu…

Testicular cancer

August 24, 2016 ASSSA Man

Testicular cancer is a disease in which malignant (cancerous) cells are formed in the tissue of one …

ASSSA Magazine 33Jan - Jun 2024

ASSSA Magazine 32Jul - Dec 2023

ASSSA Magazine 31Jan - Jun 2023

ASSSA Magazine 30Jul - Dec 2022

View all magazines

Cookies policy Privacy policy Legal notice Desarrollado por Espira

    WE CALL YOU

    Please, fill in the form and we call you

    Call us 965 200 106

    965 200 106

    Seleccione el idioma

    Escoja el idioma en el que quiere leer el blog

    Close

    NOTA INFORMATIVA

    REGLAMENTO PARA LA DEFENSA DEL ASEGURADO DE ASSSA

    Este reglamento tiene por objeto regular el funcionamiento del Servicio de Atención al Cliente y del Defensor del Asegurado de ASSSA, así como las relaciones entre ambos. Se rige por la Ley 44/2002 de 22 de noviembre, de Medidas de Reforma del Sistema Financiero y por la Orden ECO 734/2004, de 11 de marzo, sobre los departamentos y servicios de atención al cliente de las entidades financieras.

    El Reglamento para la defensa del asegurado puede solicitarlo en la siguiente dirección de correo: sacquejasyreclamaciones@asssa.es.

    Close

    INFORMATION ON THE DENTAL MEDICAL DIRECTORY

    EXCLUSIVELY FOR POLICYHOLDERS WITH A DENTAL INSURANCE POLICY

    CONTINUE